Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

NASDAQ:BYRN - Nasdaq - US12448X2018 - Common Stock - Currency: USD

21.13  +0.97 (+4.81%)

Premarket: 20.74 -0.39 (-1.85%)

Fundamental Rating

6

BYRN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. BYRN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BYRN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BYRN had positive earnings in the past year.
In the past year BYRN had a positive cash flow from operations.
In the past 5 years BYRN reported 4 times negative net income.
In multiple years BYRN reported negative operating cash flow during the last 5 years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

BYRN has a Return On Assets of 20.32%. This is amongst the best in the industry. BYRN outperforms 98.46% of its industry peers.
BYRN has a Return On Equity of 25.40%. This is amongst the best in the industry. BYRN outperforms 93.85% of its industry peers.
The Return On Invested Capital of BYRN (11.46%) is better than 92.31% of its industry peers.
Industry RankSector Rank
ROA 20.32%
ROE 25.4%
ROIC 11.46%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

BYRN has a Profit Margin of 15.15%. This is amongst the best in the industry. BYRN outperforms 92.31% of its industry peers.
The Operating Margin of BYRN (8.95%) is comparable to the rest of the industry.
BYRN's Gross Margin of 61.97% is amongst the best of the industry. BYRN outperforms 95.38% of its industry peers.
In the last couple of years the Gross Margin of BYRN has grown nicely.
Industry RankSector Rank
OM 8.95%
PM (TTM) 15.15%
GM 61.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BYRN is still creating some value.
The number of shares outstanding for BYRN has been increased compared to 1 year ago.
The number of shares outstanding for BYRN has been increased compared to 5 years ago.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BYRN has an Altman-Z score of 21.49. This indicates that BYRN is financially healthy and has little risk of bankruptcy at the moment.
BYRN has a Altman-Z score of 21.49. This is amongst the best in the industry. BYRN outperforms 100.00% of its industry peers.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.49
ROIC/WACC1.16
WACC9.84%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.99 indicates that BYRN has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.99, BYRN belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
BYRN has a Quick Ratio of 2.09. This indicates that BYRN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BYRN (2.09) is better than 75.38% of its industry peers.
Industry RankSector Rank
Current Ratio 3.99
Quick Ratio 2.09
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1700.00% over the past year.
The Revenue has grown by 87.24% in the past year. This is a very strong growth!
The Revenue has been growing by 147.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)87.24%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%57.26%

3.2 Future

BYRN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.20% yearly.
Based on estimates for the next years, BYRN will show a quite strong growth in Revenue. The Revenue will grow by 18.79% on average per year.
EPS Next Y-36.94%
EPS Next 2Y10.58%
EPS Next 3Y1.2%
EPS Next 5YN/A
Revenue Next Year30.9%
Revenue Next 2Y26.19%
Revenue Next 3Y28.57%
Revenue Next 5Y18.79%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

BYRN is valuated quite expensively with a Price/Earnings ratio of 33.02.
63.08% of the companies in the same industry are more expensive than BYRN, based on the Price/Earnings ratio.
BYRN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.33, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 27.87 indicates a quite expensive valuation of BYRN.
BYRN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BYRN is cheaper than 66.15% of the companies in the same industry.
BYRN is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.37, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.02
Fwd PE 27.87
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BYRN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 44.27
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

BYRN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.58%
EPS Next 3Y1.2%

More info and screens

0

5. Dividend

5.1 Amount

BYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (4/22/2025, 8:00:01 PM)

Premarket: 20.74 -0.39 (-1.85%)

21.13

+0.97 (+4.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-10 2025-04-10/bmo
Earnings (Next)07-07 2025-07-07/bmo
Inst Owners52.81%
Inst Owner Change0.05%
Ins Owners19.38%
Ins Owner Change0.95%
Market Cap479.02M
Analysts84
Price Target36.34 (71.98%)
Short Float %15.93%
Short Ratio4.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)175.38%
Min EPS beat(2)96.08%
Max EPS beat(2)254.68%
EPS beat(4)4
Avg EPS beat(4)157.7%
Min EPS beat(4)47.04%
Max EPS beat(4)254.68%
EPS beat(8)6
Avg EPS beat(8)-2.94%
EPS beat(12)7
Avg EPS beat(12)-16.34%
EPS beat(16)9
Avg EPS beat(16)13.78%
Revenue beat(2)1
Avg Revenue beat(2)-0.26%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)1.52%
Revenue beat(4)2
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)5.2%
Revenue beat(8)4
Avg Revenue beat(8)3.84%
Revenue beat(12)4
Avg Revenue beat(12)-1.38%
Revenue beat(16)6
Avg Revenue beat(16)1.81%
PT rev (1m)0%
PT rev (3m)39.02%
EPS NQ rev (1m)-28.2%
EPS NQ rev (3m)-41.66%
EPS NY rev (1m)-21.4%
EPS NY rev (3m)-16.85%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)7.84%
Revenue NY rev (1m)2.45%
Revenue NY rev (3m)1.29%
Valuation
Industry RankSector Rank
PE 33.02
Fwd PE 27.87
P/S 5.03
P/FCF N/A
P/OCF 119.16
P/B 8.43
P/tB 9.34
EV/EBITDA 44.27
EPS(TTM)0.64
EY3.03%
EPS(NY)0.76
Fwd EY3.59%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.18
OCFY0.84%
SpS4.2
BVpS2.51
TBVpS2.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 20.32%
ROE 25.4%
ROCE 14.51%
ROIC 11.46%
ROICexc 17.05%
ROICexgc 19.83%
OM 8.95%
PM (TTM) 15.15%
GM 61.97%
FCFM N/A
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score7
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 302.45%
Cap/Sales 5.06%
Interest Coverage 250
Cash Conversion 39.71%
Profit Quality N/A
Current Ratio 3.99
Quick Ratio 2.09
Altman-Z 21.49
F-Score7
WACC9.84%
ROIC/WACC1.16
Cap/Depr(3y)202.29%
Cap/Depr(5y)309.93%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y-36.94%
EPS Next 2Y10.58%
EPS Next 3Y1.2%
EPS Next 5YN/A
Revenue 1Y (TTM)87.24%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%57.26%
Revenue Next Year30.9%
Revenue Next 2Y26.19%
Revenue Next 3Y28.57%
Revenue Next 5Y18.79%
EBIT growth 1Y243.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year242.62%
EBIT Next 3Y81.08%
EBIT Next 5Y53.44%
FCF growth 1Y92.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y145.84%
OCF growth 3YN/A
OCF growth 5YN/A